HUP0105474A2 - Krónikus vírusfertőzések kezelése M. vaccae-val - Google Patents

Krónikus vírusfertőzések kezelése M. vaccae-val

Info

Publication number
HUP0105474A2
HUP0105474A2 HU0105474A HUP0105474A HUP0105474A2 HU P0105474 A2 HUP0105474 A2 HU P0105474A2 HU 0105474 A HU0105474 A HU 0105474A HU P0105474 A HUP0105474 A HU P0105474A HU P0105474 A2 HUP0105474 A2 HU P0105474A2
Authority
HU
Hungary
Prior art keywords
vaccae
reatment
chronic viral
viral infections
chronic
Prior art date
Application number
HU0105474A
Other languages
English (en)
Inventor
Graham Arthur William Rook
Cynthia Ann Stanford
John Lawson Stanford
Original Assignee
Stanford Rook Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Limited filed Critical Stanford Rook Limited
Publication of HUP0105474A2 publication Critical patent/HUP0105474A2/hu
Publication of HUP0105474A3 publication Critical patent/HUP0105474A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya Mycobacterium vaccae (M. vaccae) készítményalkalmazása krónikus vírusfertőzés, kivéve a HIV-fertőzést, kezeléséreszolgáló gyógyszer előállítására. Ó
HU0105474A 1999-02-16 2000-02-16 Treatment of chronic viral infections with m. vaccae HUP0105474A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903539.6A GB9903539D0 (en) 1999-02-16 1999-02-16 Therapy using M.Vaccae

Publications (2)

Publication Number Publication Date
HUP0105474A2 true HUP0105474A2 (hu) 2002-05-29
HUP0105474A3 HUP0105474A3 (en) 2003-11-28

Family

ID=10847890

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105474A HUP0105474A3 (en) 1999-02-16 2000-02-16 Treatment of chronic viral infections with m. vaccae

Country Status (26)

Country Link
US (1) US6596282B1 (hu)
EP (1) EP1152768B1 (hu)
JP (1) JP2002537266A (hu)
KR (1) KR20010113691A (hu)
CN (1) CN1377274A (hu)
AP (1) AP2001002254A0 (hu)
AT (1) ATE246930T1 (hu)
AU (1) AU766113B2 (hu)
BR (1) BR0008269A (hu)
CA (1) CA2361925A1 (hu)
DE (1) DE60004481T2 (hu)
DK (1) DK1152768T3 (hu)
ES (1) ES2204508T3 (hu)
GB (1) GB9903539D0 (hu)
HK (1) HK1038697B (hu)
HU (1) HUP0105474A3 (hu)
ID (1) ID30441A (hu)
MX (1) MXPA01008243A (hu)
NO (1) NO20013939L (hu)
NZ (1) NZ513320A (hu)
PL (1) PL350577A1 (hu)
PT (1) PT1152768E (hu)
RU (1) RU2001125429A (hu)
TR (1) TR200102388T2 (hu)
WO (1) WO2000048615A2 (hu)
ZA (1) ZA200106248B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
CN111281893B (zh) * 2020-03-02 2021-11-19 广西医科大学第一附属医院 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8917256D0 (en) 1989-07-28 1989-09-13 Univ London Biological preparation and its use
GB8919321D0 (en) 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens
MXPA00006168A (es) 1997-12-23 2005-02-24 Genesis Res & Dev Corp Ltd Composiciones derivadas de mycrobacterium vaccae y metodos para su uso.

Also Published As

Publication number Publication date
NZ513320A (en) 2004-04-30
JP2002537266A (ja) 2002-11-05
US6596282B1 (en) 2003-07-22
HK1038697A1 (en) 2002-03-28
HUP0105474A3 (en) 2003-11-28
GB9903539D0 (en) 1999-04-07
PT1152768E (pt) 2003-12-31
ZA200106248B (en) 2002-01-23
AP2001002254A0 (en) 2001-09-30
HK1038697B (zh) 2004-03-19
NO20013939D0 (no) 2001-08-14
EP1152768A2 (en) 2001-11-14
TR200102388T2 (tr) 2002-10-21
ES2204508T3 (es) 2004-05-01
NO20013939L (no) 2001-10-04
WO2000048615A2 (en) 2000-08-24
ATE246930T1 (de) 2003-08-15
PL350577A1 (en) 2002-12-30
DK1152768T3 (da) 2003-11-24
CA2361925A1 (en) 2000-08-24
RU2001125429A (ru) 2003-06-10
BR0008269A (pt) 2001-11-06
DE60004481D1 (de) 2003-09-18
EP1152768B1 (en) 2003-08-13
MXPA01008243A (es) 2002-08-30
CN1377274A (zh) 2002-10-30
AU2561100A (en) 2000-09-04
KR20010113691A (ko) 2001-12-28
WO2000048615A3 (en) 2000-12-14
AU766113B2 (en) 2003-10-09
ID30441A (id) 2001-12-06
DE60004481T2 (de) 2004-06-24

Similar Documents

Publication Publication Date Title
DE50102597D1 (de) Arzneimittel gegen virale erkrankungen
ATE475423T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
TW200501935A (en) Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
HK1097467A1 (en) Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
HUP0105474A2 (hu) Krónikus vírusfertőzések kezelése M. vaccae-val
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
HRP20040186B1 (en) Use of lhrh-antagonists for the improvement of t-cell mediated immunity
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
AU4111600A (en) The use of gssg reductase for the therapy and prophylaxis of hiv infected patients
NZ512850A (en) Treatment of papillomavirus infections
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
EP1546415A4 (en) ANTI-TSG101 ANTIBODIES AND USES THEREOF FOR TREATING VIRAL INFECTIONS
SG163601A1 (en) Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
WO2001097749A3 (en) The use of synthetic, non-hormonal 21-aminosteroids and thereof
AP2003002847A0 (en) Immunomodulator for the management of human immunodeficiency virus (HIV) disease / infection.
ES2195861T3 (es) Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb.
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
AP9801368A0 (en) Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection
WO2004016228A3 (en) HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS
AP2003002852A0 (en) Natural antibodies active against HIV virus
ES2155515T3 (es) Derivados de difluorostatona macrociclica utiles como agentes antivirales.
AU2003255866A8 (en) Gp41 epitope and uses thereof for the treatment of hiv infections